QualityStocksNewsBreaks Archives - Page 763 of 1452

MondayMar 22, 2021 1:53 pm

QualityStocksNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Conference Call to Discuss Q4 Numbers, Clinical Pipeline Update

Processa Pharmaceuticals Inc. (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, has scheduled a conference call to discuss its fourth-quarter financial report as well as to provide a drug-development update. The conference call and life webcast will be available to any participants dialing or logging in. Interested parties can dial 877-545-0320 in the United States or 973-528-0016 for international calls; the entry code is the same for both: 805295. A replay of the call will be available as well. To access that, interested parties can…

MondayMar 22, 2021 1:22 pm

QualityStocksNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Presents Data Regarding Drug Candidate for Replacement of Addictive Benzodiazepines

VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new-generation medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, presented data highlighting the proposed mechanism of action (“MOA”) of its Phase 3 investigational drug candidate, PH94B nasal spray, in a poster session at the Anxiety and Depression Association of America’s 2021 Virtual Annual Conference. VTGN’s PH94B spray is designed to provide rapid-onset acute treatment of anxiety without directly activating gamma-amino butyric acid (“GABA-A”) receptors. This approach differentiates PH94B from benzodiazepines such as alprazolam, diazepam and lorazepam, which are…

MondayMar 22, 2021 12:10 pm

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces 2020 Results and Transformative Year, to Host Webcast on March 23, 2021

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based uranium mining company, today reported its financial results for the year-ended December 31, 2020. The company also announced that it will host a video webcast at 4:00 p.m. ET (2:00 p.m. MT) on Tuesday, March 23, 2021, to discuss its 2020 financial results and other corporate initiatives. Interested parties should visit https://ibn.fm/qE1UK to register for and join the webcast and to access the presentation and viewer-controlled webcast slides. "2020 was a transformative year for Energy Fuels, as we worked on developing a rare earth business complementary to our core uranium business,"…

MondayMar 22, 2021 11:03 am

QualityStocksNewsBreaks – Asia Broadband Inc. (AABB) Launches Sales of Gold-Backed Cryptocurrency Token

Asia Broadband (OTC: AABB)announced the sales launch of its AABB Gold (“AABBG”) cryptocurrency token. The token was developed by Core State Holdings Corp. (“CSHC”). The announcement noted that AABB Wallet users who want to purchase the new tokens must update the AABB Wallet app or install the latest version of the app as well as pass the Know Your Client (“KYC”) process. Because the new token will only be available for purchase in exchange for other major cryptocurrencies including Bitcoin, Ethereum and Litecoin, those wanting to purchase AABB Gold token will need to own cryptocurrency in a third-party wallet. To…

MondayMar 22, 2021 10:57 am

QualityStocksNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Secures $30.5M in Registered Direct Offering

Uranium Energy (NYSE American: UEC), a Corpus Christi, Texas-based uranium mining and exploration company, has closed its previously announced offering of an aggregate of 10,000,000 shares of common stock of the company. Per an update released today, Uranium Energy secured gross proceeds of $30,500,000 in the registered direct offering, with each of the shares sold at a purchase price of $3.05. The company offered and sold the shares per a securities purchase agreement, dated March 17, 2021, with certain institutional investors. UEC intends to use the net proceeds for additional uranium purchases and for general corporate and working capital purposes.…

MondayMar 22, 2021 10:40 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Enters Strategic Drug Development Agreement with Catalent Inc. (NYSE: CTLT)

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced its entry into a drug development agreement with Catalent (NYSE: CTLT), the leading global provider of advanced delivery technologies, development and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. According to the update, Cybin will be applying Catalent’s proprietary Zydis(R) orally disintegrating tablet (“ODT”) technology for the delivery of its novel deuterated tryptamine (“CYB003”), a potential therapy for treatment-resistant psychiatric disorders. “We are excited to partner with the team at Catalent with the aim of developing fast-acting, shorter-duration formulations of…

MondayMar 22, 2021 10:18 am

QualityStocksNewsBreaks – Grapefruit USA Inc. (GPFT) Announces Increased Bioavailabilty for Flagship THC/CBD-Infused Cream

Grapefruit USA (OTCQB: GPFT), a premiere, fully licensed California-based cannabis company, has reached another technological milestone in the proprietary manufacturing process for its patented, disruptive Hourglass(TM) time-release THC+ cannabinoid delivery cream. In the announcement, the company noted that continued research and analysis of the manufacturing process have led to a substantial reduction in the size of the cream’s THC/CBD-infused particles. The mean particle size now measures 8.2 microns compared to previous samples, which averaged 33.1 and 29.9 microns. The company consistently analyzes the process with the intent of reducing the size of the infused particles, which leads to an increased…

MondayMar 22, 2021 10:05 am

QualityStocksNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Completes Enrollment in Phase 2 MS1819-PERT Combination Clinical Trial

AzurRx BioPharma (NASDAQ: AZRX), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, today announced completion of enrollment in its Phase 2 trial evaluating MS1819 in combination with the current standard of care, porcine-derived pancreatic enzyme replacement therapy (“PERT”). The combination trial is for the treatment of severe exocrine pancreatic insufficiency (“EPI”) in patients with cystic fibrosis (“CF”). “We are very pleased to have completed enrollment in our Phase 2 MS1819 plus PERT combination therapy clinical trial,” said James Sapirstein, president, CEO and chairman of AzurRx. “Based on the very encouraging clinical results…

MondayMar 22, 2021 9:51 am

QualityStocksNewsBreaks – Knightscope K5 Deployed to Assist in Protection of California Casino

Knightscope, an advanced security technology company that builds fully autonomous security robots that deter, detect and report, has reported that it has completed another new deployment. According to the announcement, the company’s robotics are now at work in Santa Ynez, California, as the newest member of the Chumash Casino security team. A Knightscope K5 will be assisting in the protection of Chumash’s 115,000-square-foot casino, which is part of a AAA four-diamond-rated hotel that offers 320 rooms and 58 suites. “The watchful K5 will patrol the five-story resort parking structure to help keep visitors, staff and their vehicles safe,” the announcement…

MondayMar 22, 2021 9:24 am

QualityStocksNewsBreaks – Rritual Superfoods Inc. (CSE: RSF) Provides Update on Manufacturing Run, Plans to Launch Elixirs

Rritual Superfoods (CSE: RSF) (CSE: RSF.WT), a functional superfood company that creates plant-based elixirs that support immunity, focus and relaxation, has announced the successful completion of its second full-scale manufacturing run; the company also announced plans to start its third full-scale manufacturing run early next month. The announcement comes as Rritual provides an update on the anticipated launch of its plant-based superfood elixirs in the United States. In the announcement, the company noted that the second commercial scale manufacturing run was approximately 50% larger than its initial production run. The planned April run is expected to be 200% larger than the current manufacturing run,…

Site Search

Company Search

Category: QualityStocksNewsBreaks